Exploring Innovations in Cancer Immunotherapy|Søren Bregenholt, CEO, Alligator Bioscience AB. 00:10:00
Remarkable journey of Søren Bregenholt, offering profound insights into his professional trajectory leading to the helm of Alligator Bioscience. Through candid dialogue, Bregenholt elucidates the company's pioneering work in developing antibody-based pharmaceuticals for cancer treatment, emphasizing their specialization in tumour-directed immunotherapies. Listeners gain invaluable perspectives on current treatment options and the cutting-edge advancements underway at Alligator in diversifying drug therapies.
